Holen Sie sich die Stockscreener-App
14.09
0.46%
0.075
Schlusskurs vom Vortag:
$14.01
Offen:
$14.15
24-Stunden-Volumen:
2.32M
Relative Volume:
0.03
Marktkapitalisierung:
$7.31B
Einnahmen:
$1.61B
Nettoeinkommen (Verlust:
$282.33M
KGV:
26.97
EPS:
0.5223
Netto-Cashflow:
$352.16M
1W Leistung:
-21.76%
1M Leistung:
-6.48%
6M Leistung:
+17.59%
1J Leistung:
+18.28%
1-Tages-Spanne:
$13.87
$14.15
1-Wochen-Bereich:
$13.85
$18.83
52-Wochen-Spanne:
$9.2002
$19.84
Uipath Inc Stock (PATH) Company Profile
Firmenname
Uipath Inc
Sektor
Branche
Telefon
(844) 432-0455
Adresse
ONE VANDERBILT AVENUE, NEW YORK
Compare PATH vs MSFT, ORCL, PLTR, CRWD, FTNT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
14.10 | 7.26B | 1.61B | 282.33M | 352.16M | 0.5223 |
MSFT
Microsoft Corp
|
492.86 | 3.67T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
162.65 | 468.13B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
170.25 | 409.24B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
211.71 | 215.05B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
157.15 | 115.54B | 7.11B | 1.95B | 2.44B | 2.5883 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Needham | Hold → Buy |
| 2025-10-02 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Neutral |
| 2025-03-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-12 | Eingeleitet | UBS | Sell |
| 2024-06-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-05-30 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-30 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-04-08 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-03-14 | Bestätigt | Needham | Buy |
| 2024-02-21 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-01-02 | Eingeleitet | William Blair | Outperform |
| 2023-06-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-04-21 | Eingeleitet | DA Davidson | Neutral |
| 2023-03-16 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-09-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-01-25 | Hochstufung | Macquarie | Neutral → Outperform |
| 2022-01-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-09 | Hochstufung | Berenberg | Hold → Buy |
| 2021-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-12 | Eingeleitet | Summit Insights | Sell |
| 2021-05-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-05-17 | Eingeleitet | Barclays | Equal Weight |
| 2021-05-17 | Eingeleitet | BofA Securities | Buy |
| 2021-05-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-05-17 | Eingeleitet | Cowen | Outperform |
| 2021-05-17 | Eingeleitet | DA Davidson | Buy |
| 2021-05-17 | Eingeleitet | Evercore ISI | In-line |
| 2021-05-17 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-17 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-17 | Eingeleitet | Macquarie | Neutral |
| 2021-05-17 | Eingeleitet | Mizuho | Buy |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-17 | Eingeleitet | Needham | Buy |
| 2021-05-17 | Eingeleitet | Oppenheimer | Perform |
| 2021-05-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-05-17 | Eingeleitet | Truist | Buy |
| 2021-05-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-05-17 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-05-13 | Eingeleitet | Berenberg | Hold |
Alle ansehen
Uipath Inc Aktie (PATH) Neueste Nachrichten
Public Employees Retirement System of Ohio Takes $1.25 Million Position in UiPath, Inc. $PATH - MarketBeat
Is The Pullback In UiPath Stock A Glitch Or A Feature? - Trefis
Why UiPath (PATH) Stock Is Trading Lower Today - Yahoo Finance
UiPath, Inc. 2026: Revenue $410.26M, Net income $36.09M, EPS $0.07— 10-Q Summary - tradingview.com
UiPath (PATH) boosts profit and buys back shares, but its cash balance moves too - Stock Titan
UiPath retreats 8%, extending post-earnings selloff (PATH:NYSE) - Seeking Alpha
Citi Just Upgraded UiPath Stock. Here's Why. - Yahoo Finance
UiPath and Pegasystems Sink 7% as Price Target Hikes Arrive Without a Single Buy Rating - Yahoo Finance
Synthesized Launches UiPath Integration to Automate Test Data Provisioning for Continuous Testing - Yahoo! Finance Canada
PATH Stock Slides As Traders Question AI Growth Story - StocksToTrade
PATH Stock Plunges After Earnings As Traders Weigh BofA Call - timothysykes.com
UiPath at Citi’s 2026 Global TMT Conference: platform push deepens By Investing.com - Investing.com India
UiPath (NYSE:PATH) Trading Down 6.7%What's Next? - MarketBeat
UiPath Slides 24% After Q2 Earnings: Is PATH Stock a Buy? - tradingview.com
PATH Looks 14.4% Undervalued on GF Value™ - GuruFocus
Citigroup Initiates UiPath at Buy With $23 Price Target - marketscreener.com
PATH Stock Wrapped Its Worst Week In 4 Months: UiPath Wins Higher Price Targets, But Analysts Still Want AI Proof - Stocktwits
Does UiPath’s (PATH) New CFO and 2027 Guidance Reframe Its Automation Profitability Story? - simplywall.st
UiPath (PATH) Stock Plunges 16%: Should Investors Buy the Dip After Q2 Earnings? - Blockonomi
PATH stock: Can UiPath keep its RPA lead? - CMC Markets
UiPath, Inc. (PATH) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Weekly Recap: Q2 guidance boost for UiPath (PATH) and AI deal adoption - tradingview.com
Why UiPath Stock Fell 17% Last Week Despite Beating Estimates - tikr.com
Why is UiPath (NYSE:PATH) in focus during the Labor Day market pause? - kalkinemedia.com
UiPath Just Sank 17%. Is the Stock a Buy on the Dip? - Yahoo Finance
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 125,770 Shares of UiPath, Inc. $PATH - MarketBeat
Bank of America and Truist Raise UiPath Price Targets Amid AI Growth Concerns - intellectia.ai
Why UiPath Rallied in August - Yahoo Finance
UiPath Stock Falls 17%; Its $13 Million Guide Raise Adds Just $0.2 Million to the Second Half - TechStock²
Odyssean LLC Makes New Investment in UiPath, Inc. $PATH - MarketBeat
UiPath, Inc. Tokenized Stock (Robinhood) to Chinese Yuan Price Today | Live PATH to CNY Converter & Exchange Rate - CryptoRank
AXQ Capital LP Acquires New Stake in UiPath, Inc. $PATH - MarketBeat
Why UiPath Stock Plunged Today - The Motley Fool
UiPath (PATH) Grew ARR 12% as Net Retention Rate Reached 109%. Can Agentic Automation Reaccelerate Expansion? - Yahoo Finance
Uipath Stock Price Forecast. Should You Buy PATH? - StockInvest.us
A Look at UiPath Inc (PATH) After 16.6% Decline -- GF Value $16. - GuruFocus
UiPath Inc (PATH) Stock Price, Quote, News & History - Benzinga
UiPath tumbles 17% as doubts linger about growth reacceleration (PATH:NYSE) - Seeking Alpha
UiPath Posts 13% Revenue Jump in Q2 2027, Misses on EPS - AlphaStreet
UiPath Stock Plummets on AI Competition Fears, Despite Revenue Beat - Barron's
UiPath Shares Slide 7% Despite Upbeat Revenue and Raised Guidance - finance.biggo.com
UiPath (PATH) Could Be 15% Undervalued After Q2 Beat And Higher Revenue Outlook - Yahoo Finance
UiPath’s AI Momentum Soars, But Stock Ran Too FarUiPath (NYSE:PATH) - Benzinga
Truist Financial Forecasts Strong Price Appreciation for UiPath (NYSE:PATH) Stock - MarketBeat
Why UiPath (PATH) Stock Is Falling Today - tradingview.com
UiPath's AI-Driven Deal Momentum, new Product Traction in Q2 are Encouraging, RBC Says - marketscreener.com
UiPath (NYSE:PATH) Given New $14.00 Price Target at Mizuho - MarketBeat
UiPath Stock Drops 17% as ARR Target Demands 75% Faster Second Half - TechStock²
UiPath (NYSE:PATH) Price Target Raised to $15.00 at Bank of America - MarketBeat
UiPath Posts Solid Fiscal Q2, Growth Re-acceleration Remains Limited, Oppenheimer Says - marketscreener.com
DA Davidson maintains UiPath stock rating on stable growth outlook - Investing.com
Finanzdaten der Uipath Inc-Aktie (PATH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):